Company
Headquarters: Guilford, CT, United States
Employees: 153
CEO: Dr. Jonathan M. Rothberg Ph.D.
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $158.96 B |
| Vertex Pharmaceuticals Incorporated | $115.92 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $82.28 B |
| Marinomed Biotech AG | $70.11 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Quantum-Si incorporated, a life sciences company, operates single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for semiconductor industry to field proteomics to enable next generation protein sequencing. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4C Holdings I, LLC.
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $1.1 M |
| EBITDA | $-102,511,000 |
| Gross Profit TTM | $488,000 |
| Profit Margin | 45.10% |
| Operating Margin | -6877.50% |
| Quarterly Revenue Growth | 79.37% |
Quantum-Si, Inc. has the following listings and related stock indices.
Stock: NASDAQ: QSI